Chairman Li Qiling increased his holdings of DAWNRAYS PHARMA (02348) by 52,000 shares at a price of HK$1.22 per share.

According to the latest data from the Hong Kong Stock Exchange, on November 3, Chairman Li Qiling increased his stake in DAWNRAYS PHARMA (02348) by 52,000 shares, with a price of 1.22 Hong Kong dollars per share, totaling approximately 63,400 Hong Kong dollars. After the increase, the latest number of shares held is approximately 711 million shares, with a latest shareholding ratio of 47.26%. This transaction involves another related party: Xiong Rongli.